Trial Profile
Lofexidine Pharmacokinetics in the Presence of Paroxetine, a Strong CYP2D6 Inhibitor, in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary) ; Paroxetine
- Indications Opioid-related disorders; Substance withdrawal syndrome
- Focus Pharmacokinetics
- Sponsors US WorldMeds
- 02 May 2016 New trial record